News GSK will file oral carbapenem for complicated UTIs this year GSK and Spero's cabapenem tebipenem is the first oral antibiotic in the class to show efficacy in complicated urinary tract infections.
News ViiV's bimonthly HIV PrEP jab cleared for use by NHS ViiV's injectable HIV PrEP Apretude will soon be an alternative for people in England and Wales who cannot use daily oral options.
R&D Sponsored Why conditions like UTI call for new antibiotics Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.
News Walmsley to leave GSK in surprise exit This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.
News As Trump visits UK, GSK pledges $30bn in US investment GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.